Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
WCG Clinical | Insights
What Is a Biological Safety Cabinet? Do We Need One to Prepare Our Gene Therapy Product?
Blog Posts
WCG Clinical | Insights
Do You Need to Submit an Updated Protocol to the IBC After Already Receiving Approval?
Blog Posts
WCG Clinical | Insights
Why do Community Members Need to Participate in IBC Review Meetings?
Blog Posts
WCG Clinical | Insights
If a site needs to submit to create an IBC with WCG, how long does the NIH registration process typically take?
Blog Posts
WCG Clinical | Insights
What Is Expedited Review?
Blog Posts
WCG Clinical | Insights
What Information Must Be Included in the Cost Section of an Informed Consent Form?
Blog Posts
WCG Clinical | Insights
Why Was My Research Submission/Protocol Deferred? And What Should I Do?
Blog Posts
WCG Clinical | Insights
IRB Submission Requirements for Decentralized Clinical Trials
Blog Posts
WCG Clinical | Insights
Post Study Activities Requiring IRB Review
Blog Posts
WCG Clinical | Insights